Evidence map›Paper›PMID 30989053›Full record

ArticleIDCases2019

Non-O1, non-O139

John Shanley, Amjad Kanj, Said El Zein, Hussam Tabaja, Brett Trzcinski, Julian Horman, Hossein Salimnia, Marilynn Fairfax, Manmeet Singh

Open access · goldAbstract readCase Reports
In one paragraph

Article in IDCases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Clinical case reports · 2025
    Article
  4. Think Vibrio, Think Rare: Non-O1-Non-O139-Tropical medicine and infectious disease · 2024
    Article
  5. Tropical medicine and infectious disease · 2024
    Article
  6. Article
  7. Bacteremia by non-O1/non-O139 Vibrio cholerae: Case description and literature review.Biomedica : revista del Instituto Nacional de Salud · 2023
    Review
  8. Article
  9. Whole Genome Analysis of a Non-O1, Non-O139Infection and drug resistance · 2023
    Article
  10. Article
  11. Review
  12. Non-O1, Non-O139Infection and drug resistance · 2020
    Article
  13. High Mortality With Non-O1/Non-O139Journal of clinical and experimental hepatology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

John ShanleyWayne State University School of Medicine, Detroit, MI, United States.
Amjad KanjDepartment of Internal Medicine, Wayne State University, Detroit, MI, United States.
Said El ZeinDepartment of Internal Medicine, Wayne State University, Detroit, MI, United States.
Hussam TabajaDepartment of Internal Medicine, Wayne State University, Detroit, MI, United States.
Brett TrzcinskiDepartment of Internal Medicine, Wayne State University, Detroit, MI, United States.
Julian HormanWayne State University School of Medicine, Detroit, MI, United States.
Hossein SalimniaDivision of Pathology, Wayne State University, Detroit, MI, United States.
Marilynn FairfaxDivision of Pathology, Wayne State University, Detroit, MI, United States.
Manmeet SinghDepartment of Internal Medicine, Wayne State University, Detroit, MI, United States.
Wayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-O1, non-O139

Identifiers

PMID30989053
PMCPMC6447745
OpenAlexW2924026063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.